menu
    • menu

    Company profile for Humanigen

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Humanigen, Inc. is developing its portfolio of clinical and pre-clinical therapies for the treatment of cancers and infectious diseases via its novel, cutting-edge GM-CSF neutralization and gene-knockout platforms. We believe that our GM-CSF neutralization and gene-editing platform technologies have the potential to reduce the inflammatory cascade associated with coronavirus infection as well as the serious and potentially li...
    Humanigen, Inc. is developing its portfolio of clinical and pre-clinical therapies for the treatment of cancers and infectious diseases via its novel, cutting-edge GM-CSF neutralization and gene-knockout platforms. We believe that our GM-CSF neutralization and gene-editing platform technologies have the potential to reduce the inflammatory cascade associated with coronavirus infection as well as the serious and potentially life-threatening CAR-T therapy-related side effects while preserving and potentially improving the efficacy of the CAR-T therapy itself, thereby breaking the efficacy/toxicity linkage.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HumanigenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    533 Airport Blvd #400, Burlingame, CA 94010, USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.humanigen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/humanigen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Humanigen mulls bankruptcy after reverse merger falls through
    Humanigen mulls bankruptcy after reverse merger falls through

    25 Jul 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astellas-notches-another-protein-degrader-pact-21m-upfront-peptidream-partnership

    Nick Paul Taylor FIERCE BIOTECH
    25 Jul 2023
    Share Share
    Humanigen Reports Second Quarter 2022 Financial Results
    Humanigen Reports Second Quarter 2022 Financial Results

    12 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220812005104/en

    BUSINESSWIRE
    12 Aug 2022
    Share Share
    Humanigen's stock sinks as COVID-19 prospect flunks NIH trial
    Humanigen's stock sinks as COVID-19 prospect flunks NIH trial

    14 Jul 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/humanigens-covid-19-prospect-flunks-nih-trial-sinking-stock-and-raising-doubts-about-its

    Nick Paul Taylor FIERCEBIOTECH
    14 Jul 2022
    Share Share
    Humanigen Announces Peer-Reviewed Publication in Thorax in COVID-19 Patients
    Humanigen Announces Peer-Reviewed Publication in Thorax in COVID-19 Patients

    06 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220706005311/en

    BUSINESSWIRE
    06 Jul 2022
    Share Share
    NIH/NIAID Locks ACTIV-5/BET-B Database
    NIH/NIAID Locks ACTIV-5/BET-B Database

    30 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220630005489/en

    BUSINESSWIRE
    30 Jun 2022
    Share Share
    Humanigen Enters into Agreement with PCI Pharma Services in the UK
    Humanigen Enters into Agreement with PCI Pharma Services in the UK

    16 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220616005133/en

    BUSINESSWIRE
    16 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search